Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | beta-site APP-cleaving enzyme 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | memapsin-2 (A01 family) | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Schistosoma japonicum | ko:K07747 beta-site APP-cleaving enzyme 2 (memapsin 1) [EC3.4.23.45], putative | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin VII | beta-site APP-cleaving enzyme 1 | 401 aa | 352 aa | 21.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | ectoderm neural cortex protein 1 | 0.0002 | 0.0003 | 0.0003 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Plasmodium falciparum | plasmepsin VI | 0.0021 | 0.0283 | 0.5 |
Echinococcus multilocularis | kelch ECH associated protein 1 | 0.0673 | 0.9972 | 0.9972 |
Plasmodium falciparum | plasmepsin X | 0.0021 | 0.0283 | 0.5 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0021 | 0.0283 | 0.5 |
Echinococcus granulosus | kelch protein 3 | 0.0002 | 0.0003 | 0.0003 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0021 | 0.0283 | 0.0283 |
Echinococcus multilocularis | kelch protein 18 | 0.0002 | 0.0003 | 0.0003 |
Plasmodium vivax | aspartyl protease, putative | 0.0021 | 0.0283 | 0.5 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0021 | 0.0283 | 0.0748 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Onchocerca volvulus | 0.0021 | 0.0283 | 1 | |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Loa Loa (eye worm) | Klhl5 protein | 0.0002 | 0.0003 | 0.01 |
Echinococcus granulosus | kelch ECH associated protein 1 | 0.0673 | 0.9972 | 1 |
Plasmodium vivax | plasmepsin IV, putative | 0.0021 | 0.0283 | 0.5 |
Echinococcus multilocularis | kelch ECH associated protein 1 | 0.0673 | 0.9972 | 0.9972 |
Echinococcus granulosus | kelch ECH associated protein 1 like | 0.0673 | 0.9972 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0256 | 0.3781 | 0.3792 |
Echinococcus granulosus | kelch protein 10 | 0.0002 | 0.0003 | 0.0003 |
Schistosoma mansoni | hypothetical protein | 0.0256 | 0.3781 | 0.3781 |
Brugia malayi | hypothetical protein | 0.0256 | 0.3781 | 1 |
Plasmodium falciparum | plasmepsin I | 0.0021 | 0.0283 | 0.5 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0021 | 0.0283 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0256 | 0.3781 | 0.3781 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0521 | 0.771 | 0.771 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Plasmodium falciparum | plasmepsin IV | 0.0021 | 0.0283 | 0.5 |
Plasmodium falciparum | plasmepsin V | 0.0021 | 0.0283 | 0.5 |
Brugia malayi | Kelch motif family protein | 0.0002 | 0.0003 | 0.0007 |
Loa Loa (eye worm) | aspartyl protease 6 | 0.0021 | 0.0283 | 1 |
Plasmodium falciparum | plasmepsin III | 0.0021 | 0.0283 | 0.5 |
Toxoplasma gondii | aspartyl protease | 0.0021 | 0.0283 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0283 | 0.0748 |
Onchocerca volvulus | 0.0021 | 0.0283 | 1 | |
Echinococcus multilocularis | kelch protein 12 | 0.0002 | 0.0003 | 0.0003 |
Brugia malayi | Kelch-like protein X | 0.0002 | 0.0003 | 0.0007 |
Echinococcus granulosus | kelch protein 12 | 0.0002 | 0.0003 | 0.0003 |
Plasmodium falciparum | plasmepsin II | 0.0021 | 0.0283 | 0.5 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0021 | 0.0283 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0256 | 0.3781 | 0.3781 |
Brugia malayi | Kelch motif family protein | 0.0002 | 0.0003 | 0.0007 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0021 | 0.0283 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Plasmodium falciparum | plasmepsin VIII, putative | 0.0021 | 0.0283 | 0.5 |
Plasmodium falciparum | plasmepsin IX | 0.0021 | 0.0283 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0283 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Entamoeba histolytica | hypothetical protein | 0.0256 | 0.3781 | 0.5 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0021 | 0.0283 | 0.0748 |
Schistosoma mansoni | hypothetical protein | 0.0675 | 1 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0021 | 0.0283 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0283 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0021 | 0.0283 | 0.0748 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Plasmodium falciparum | plasmepsin VII | 0.0021 | 0.0283 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Brugia malayi | Pepsin A precursor | 0.0021 | 0.0283 | 0.0748 |
Echinococcus granulosus | kelch protein 18 | 0.0002 | 0.0003 | 0.0003 |
Echinococcus granulosus | kelch ECH associated protein 1 like | 0.0673 | 0.9972 | 1 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0021 | 0.0283 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0256 | 0.3781 | 0.5 |
Brugia malayi | hypothetical protein | 0.0021 | 0.0283 | 0.0748 |
Plasmodium vivax | aspartyl protease, putative | 0.0021 | 0.0283 | 0.5 |
Plasmodium vivax | aspartyl protease, putative | 0.0021 | 0.0283 | 0.5 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0021 | 0.0283 | 0.5 |
Loa Loa (eye worm) | ring canal kelch protein | 0.0002 | 0.0003 | 0.01 |
Echinococcus multilocularis | kelch protein 3 | 0.0002 | 0.0003 | 0.0003 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0021 | 0.0283 | 0.0284 |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | 0.0021 | 0.0283 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0256 | 0.3781 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0256 | 0.3781 | 0.5 |
Loa Loa (eye worm) | kelch domain-containing protein family protein | 0.0002 | 0.0003 | 0.01 |
Brugia malayi | BTB/POZ domain containing protein | 0.0002 | 0.0003 | 0.0007 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Plasmodium vivax | plasmepsin V, putative | 0.0021 | 0.0283 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0002 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0283 | 1 |
Echinococcus multilocularis | ectoderm neural cortex protein 1 | 0.0002 | 0.0003 | 0.0003 |
Toxoplasma gondii | eukaryotic aspartyl protease superfamily protein | 0.0021 | 0.0283 | 0.5 |
Echinococcus multilocularis | kelch protein 10 | 0.0002 | 0.0003 | 0.0003 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0021 | 0.0283 | 0.0283 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1.7 uM | Inhibition of human recombinant BACE1 using K(biotin)RGLTTRPGSGLTNIKTEEISEVNLDAEFRHDSGA as substrate after 1 hr by ELISA | ChEMBL. | 22984865 |
IC50 (binding) | > 10.2 uM | Inhibition of BACE1-mediated sAPPbeta production in human H4 cells expressing APP 695 after 18 hrs by ELISA | ChEMBL. | 22984865 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.